About this trial
This study examines the application of precision treatment intervention for smoking cessation from both the clinician perspective and patient perspective, and compares it to usual care on tobacco treatment in the primary care setting. The precision treatment intervention includes personalized tobacco treatment recommendations using the patient's clinical, genetic, and biomarker information. This approach may increase effectiveness and adherence for the patient, and increase the clinician's likelihood of prescribing.
Eligibility criteria
Qualifiers
Clinician from participating clinic
At least 18 years of age
Can speak and understand English
Patient at participating clinic
Disqualifiers
None
Trial design
Treatments tested in this trial
- Precision Treatment
- Usual Care
Treatment groups
Sponsors and collaborators
Washington University School of Medicine
Lead sponsor
National Institute on Drug Abuse (NIDA)
Collaborator
National Cancer Institute (NCI)
Collaborator